Nass et al. (2009)
The ghrelin mimetic MK-677 enhanced pulsatile GH secretion and significantly increased FFM over 12 months and was generally well tolerated. Long-term functional, and ultimately [...]
October 2009
May 2009
Bhasin et al. (2009)
This review describes the historical evolution, the rationale for SARM development, and the mechanisms of testosterone action and SARM selectivity. [...]
December 2006
Frajese et al. (2006)
The aim of this article is to critically review the available evidence from the tadalafil clinical research program and give the physician a rational [...]
July 2006
Rajfer et al. (2006)
The efficacy and safety of tadalafil, dosed once a day for the treatment of erectile dysfunction, was assessed in a randomized, double-blind, placebo-controlled, parallel-design [...]
March 2006
Teichman et al. (2006)
Subcutaneous administration of CJC-1295 resulted in sustained, dose-dependent increases in GH and IGF-I levels in healthy adults and was safe and relatively well tolerated, [...]
February 2005
Laferrére et al. (1998)
GHRP-2 is a synthetic agonist of ghrelin, the newly-discovered gut peptide which binds to the growth hormone (GH) secretagogue receptor. Ghrelin has been shown [...]
February 2004
Diamond et al. (2004)
PT-141, a cyclic heptapeptide melanocortin analog, was evaluated following intranasal administration in healthy male subjects and in Viagra-responsive erectile dysfunction (ED) patients. Erectile response [...]
November 1998
Raun et al. (1998)
The development and pharmacology of a new potent growth hormone (GH) secretagogue, ipamorelin, is described. Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2), which displays high GH [...]
April 1998
Muccioli et al. (1998)
In vitro studies have been performed to demonstrate and characterize specific binding sites for synthetic GH secretagogues (sGHS) on membranes from pituitary gland and [...]
September 1995
Lijesen et al. (1995)
A meta-analysis was conducted to assess if there is scientific ground for the use of human chorionic gonadotropin (HCG) as adjunctive therapy in the [...]